Compound
← Compound
Official website →
RELXRelx PLC
Quotes delayed by up to 15 minutes · informational, not investment advice
Escopo e origem dos dados
- Ativo
- RELX
- Moeda das demonstrações
- GBP
- Último período anual nesta tabela
- 2025-12-31
- Fonte das demonstrações
- SEC EDGAR
Data de demonstração não é horário de cotação. Dado ausente não é zero. A cobertura varia por ativo e fonte; confira o documento original antes de interpretar um número.
Fontes e metodologiaAbout the company
RELX Plc is a global enterprise that delivers data-driven analytical solutions and strategic decision-making instruments to professional and corporate clients across North America, Europe, and other international markets. Its operations are structured into four distinct divisions: Risk, Scientific, Technical & Medical…
IndustrySpecialty Business Services
Smart calendar
Organizing upcoming events...
Key metrics
What the market pays
P/E
Price divided by trailing 12-month earnings
19.83×
P/B
Price divided by book value
36.06×
EV/EBITDA
Enterprise value divided by operating cash generation
12.94×
EV/Revenue
Enterprise value divided by revenue
5.38×
What the company earns
ROE
Return on shareholders’ equity
125.5%
ROA
Return on all assets
15%
Gross margin
What remains after product costs
62.7%
Operating margin
What remains after operating the business
31.6%
Net margin
How much of each revenue unit becomes profit
23.3%
What it owes
Debt / Equity
Debt for each unit of shareholders’ equity
7.19
Total debt
Sum of borrowings
£8.91B
Cash
Cash available to cover it
£220M
Current ratio
Short-term assets divided by short-term liabilities
0.45
Free cash flow
Cash left after investing
£1.46B
Risk and growth
Beta
Moves more (>1) or less (<1) than the market
0.26
Revenue growth
Compared with the same period a year earlier
2.7%
Earnings growth
Compared with the same period a year earlier
20.2%
Dividend yield
Trailing 12-month distributions divided by price
2.8%
Market data provider figures for the latest published period. Informational, not investment advice.
Financial statements(GBP)
Income statement
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Receita | 8.55B | 9.16B | 9.43B | 9.59B |
| Custo dos produtos | -3.05B | -3.22B | -3.3B | -3.23B |
| Lucro bruto | 5.51B | 5.95B | 6.13B | 6.36B |
| Resultado operacional | 2.32B |
Follow RELX and get agent analysis of what is moving the stock.
Open Compound